Interline Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$50M
- Investors
-
3
Interline Therapeutics General Information
Description
Operator of a drug discovery firm intended to focus on systematically elucidating protein communities to define molecular mechanisms of disease. The company's firm leverages recent advancements in genomics, proteomics, structural biology, and computational chemistry to develop a precision medicine platform, enabling clients to identify new medicines targeting genetically validated signaling pathways and ensure that drug candidates comprehensively correct dysfunctional disease networks.
Contact Information
Website
www.interlinetx.comCorporate Office
- 1400 Sierra Point Parkway
- Suite 300
- Brisbane, CA 94005
- United States
Corporate Office
- 1400 Sierra Point Parkway
- Suite 300
- Brisbane, CA 94005
- United States
Interline Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 16-Nov-2021 | $50M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 04-Mar-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Interline Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 10,100,000 | $0.000100 | $1 | $1 | 1x | $1 | 18.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Interline Therapeutics Comparisons
Industry
Financing
Details
Interline Therapeutics Competitors (1)
One of Interline Therapeutics’s competitors is Dualsystems Biotech, a Formerly VC-backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dualsystems Biotech | Formerly VC-backed | Schlieren, Switzerland |
Interline Therapeutics Patents
Interline Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025212514-A2 | Methods of treating inflammatory diseases | Pending | 02-Apr-2024 | ||
| WO-2025212514-A3 | Methods of treating inflammatory diseases | Pending | 02-Apr-2024 | ||
| AU-2024284173-A1 | Methods of treating inflammatory diseases | Pending | 09-Jun-2023 | ||
| AU-2024286701-A1 | Methods of treating inflammatory diseases | Pending | 09-Jun-2023 | ||
| EP-4724437-A1 | Methods of treating inflammatory diseases | Pending | 09-Jun-2023 | A61K31/437 |
Interline Therapeutics Signals
Interline Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Resolved Ventures | Venture Capital | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Foresite Capital | Growth/Expansion | Minority |
Interline Therapeutics FAQs
-
When was Interline Therapeutics founded?
Interline Therapeutics was founded in 2020.
-
Where is Interline Therapeutics headquartered?
Interline Therapeutics is headquartered in Brisbane, CA.
-
What is the size of Interline Therapeutics?
Interline Therapeutics has 39 total employees.
-
What industry is Interline Therapeutics in?
Interline Therapeutics’s primary industry is Drug Discovery.
-
Is Interline Therapeutics a private or public company?
Interline Therapeutics is a Private company.
-
What is Interline Therapeutics’s current revenue?
The current revenue for Interline Therapeutics is .
-
How much funding has Interline Therapeutics raised over time?
Interline Therapeutics has raised $142M.
-
Who are Interline Therapeutics’s investors?
Resolved Ventures, ARCH Venture Partners, and Foresite Capital have invested in Interline Therapeutics.
-
Who are Interline Therapeutics’s competitors?
Dualsystems Biotech is a competitor of Interline Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process